Crossref
Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer
Advanced Cancer Research · 14.04.2026 · 1-44
DOI: 10.55092/acr20260004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Cancer Research, online erschienen am 14.04.2026. Verfasst von Ziliang Li und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, Z., Li, X., Guo, Q., Xu, J., Zhu, Y., Lu, J., Li, X., & Zhu, P. (2026). Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer. Advanced Cancer Research, 1-44. https://doi.org/10.55092/acr20260004
Vancouver
Li Z, Li X, Guo Q, Xu J, Zhu Y, Lu J, et al. Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer. Advanced Cancer Research. 2026:1-44. doi:10.55092/acr20260004
BibTeX
@article{Li2026,
author = {Li, Ziliang and Li, Xi and Guo, Qing and Xu, Jinhai and Zhu, Yingjie and Lu, Jiao and Li, Xinmeng and Zhu, Pingping},
title = {Malignancies of ISCs and their niche emerge as frontiers in precision therapy for colorectal cancer},
journal = {Advanced Cancer Research},
year = {2026},
pages = {1--44},
doi = {10.55092/acr20260004}
}
EUVIMED